Company lockup and quiet periods that follow IPOs are coming to an end this week for 18 companies. Another seven have scheduled IPOs along with two possible IPOs listed as day-to-day.
Biotech stocks extended their losses in the week ended Feb. 26 amid continued weakness in the broader market. Earnings came in thick and fast, with a skew ...
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Feb. 11) 10X ...